Definitively, my cup of tea. Focus on “Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site”

American Journal of Physiology - Cell Physiology

Volumn 308, Issue 10, 2015, Pages C825-C826

  Naftalin, Richard J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE TRIPHOSPHATE; CAFFEINE; CALCIUM ION; CYTOCHALASIN B; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; METHYLXANTHINE; PENTOXIFYLLINE; PHOSPHODIESTERASE; THEOPHYLLINE; TRINITROPHENYL;

ADIPOCYTE; ANTIGEN BINDING; BLOOD LEVEL; BRAIN; CELL MIGRATION; COMPUTER MODEL; CRYSTAL STRUCTURE; EDITORIAL; ERYTHROCYTE GHOST; EXERCISE; GLUCOSE TRANSPORT; HUNGER; INTERSTITIAL FLUID; MOLECULAR DOCKING; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SCANDINAVIA; SEIZURE; SUGAR TRANSPORT; TRANSPORT KINETICS; UNITED KINGDOM; UNITED STATES; HUMAN; METABOLISM;

CAFFEINE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS;

EID: 84930913849     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00083.2015     Document Type: Editorial

References (10)

1. Akiba T, Yaguchi K, Tsutsumi K, Nishioka T, Koyama I, Nomura M, Yokogawa K, Moritani S, Miyamoto KI. Inhibitory mechanism of caffeine on insulin-stimulated glucose uptake in adipose cells. Biochem Pharmacol 68: 1929-1937, 2004.
2. Blodgett DM, De Zutter JK, Levine KB, Karim P, Carruthers A. Structural basis of GLUT1 inhibition by cytoplasmic ATP. J Gen Physiol 130: 157-168, 2007.
3. Challiss JR, Taylor LP, Holman GD. Sugar transport asymmetry in human erythrocytes-the effect of bulk haemoglobin removal and the addition of methylxanthines. Biochim Biophys Acta 602: 155-166, 1980.
4. Cunningham P, Naftalin RJ. Reptation-induced coalescence of tunnels and cavities in Escherichia Coli XylE transporter conformers accounts for facilitated diffusion. J Membr Biol 247: 1161-1179, 2014.
5. Fredholm BB, Bättig K, Holmén J, Nehlig a Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133, 1999.
6. Heard KS, Fidyk N, Carruthers A. ATP-dependent substrate occlusion by the human erythrocyte sugar transporter. Biochemistry 39: 3005-3014, 2000.
7. Ho YY, Yang H, Klepper J, Fischbarg J, Wang D, De Vivo DC. Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr Res 50: 254-260, 2001.
8. Ojeda P, Perez A, Ojeda L, Vargas-Uribe M, Rivas CI, Salas M, Vera JC, Reyes AM. Noncompetitive blocking of human GLUT1 hexose transporter by methylxanthines reveals an exofacial regulatory binding site. Am J Physiol Cell Physiol 303: C530-C539, 2012.
9. Sage JM, Cura AJ, Loyd KP, Carruthers A. Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site. Am J Physiol Cell Physiol. doi:10.1152/ajpcell.00001.2015.
10. Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, Kempfle J, Wuttke TV, Weber Y, Lerche H, Afawi Z, Vandenberghe W, Korczyn AD, Berkovic SF, Ekstein D, Kivity S, Ryvlin P, Claes LRF, Deprez L, Maljevic S, Vargas A, Van Dyck T, Goossens D, Del-Favero J, Van Laere K, De Jonghe P, Van Paesschen W. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131: 1831- 1844, 2008.